Mark J. Mulvihill,Arno G. Steinig,Andrew Philip Crew,Meizhong Jin,Andrew Kleinberg,An-Hu Li,Jing Wang
申请号：
US13108024
公开号：
US08445510B2
申请日:
2011.05.16
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Compounds of Formula I, as shown below and defined herein:pharmaceutically acceptable salts thereof, synthesis, intermediates, formulations, and methods of disease treatment therewith, including treatment of cancers, such as tumors driven at least in part by at least one of RON, MET or ALK. This Abstract is not limiting of the invention.
